CLINICAL_TRIALS
trial_result
· 2021-06-03
Clinical Trial Update: Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS) [Phase 4]
Summary
Phase 4 trial update for Acthar Gel in relapsing-remitting multiple sclerosis; study terminated with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mallinckrodt ARD LLC | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: TERMINATED | Results posted: 2021-06-03